Zinc and the zebrafish

July 02, 2011

Scientists from Queen Mary, University of London have discovered a new way of detecting zinc in zebra fish, that could pave the way for furthering our understanding of diseases like type 2 diabetes, prostate cancer and Alzheimer's.

The results will be announced today (3 July) at the Sixth International Symposium on Macrocyclic and Supramolecular Chemistry, in Brighton.

Zinc is found throughout the body and involved in many metabolic pathways that affect the function of the immune system and brain, reproduction, and sexual development. Zinc is also increasingly recognised as a key element in the treatment of a range of diseases, for example type 2 diabetes, prostate cancer and Alzheimer's disease.

It's unclear whether zinc is a cause of disease, or if it's employed to prevent its development or progression, and there is great interest in developing a molecular probe which can detect zinc in the body. While a lot of work has been done in vitro, very few people have looked at how zinc works in whole organisms.

In this new study, Professor Mike Watkinson, Dr Stephen Goldup and Dr Caroline Brennan, from Queen Mary's School of Biological and Chemical Sciences, have focused their efforts on the development of a sensor for zinc to be used in studies on zebrafish (Danio rerio). Due to their fast development, zebra fish can be grown outside the mother's body, and their embryos are transparent, allowing for a clear observation of their organs.

The team designed a sensor which switched on fluorescence in the fish when zinc was present. Professor Mike Watkinson explains:"Our probe is able to visualise zinc in various parts of the fish embryos, including the pancreas and we are excited that we can develop the technology further to help understand the role of zinc in the development of important disease like Type 2 Diabetes."

The team used a technique called 'click' chemistry, which is designed to generate substances quickly and reliably by joining small units together.

The sensor was found to be particularly sensitive to identifying zinc rather than other anions such as iron or copper, and it is hoped that with further development the technology can be used by other scientists working in these important fields.
-end-


Queen Mary University of London

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.